Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
27-10-2004 - 19-11-2004
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Justification for type of information:
Data is from study report

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2005
Report date:
2005

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
Qualifier:
according to guideline
Guideline:
other: EC Directive 2000/32/EC, L 136, Annex 4D, B.13/B.14
Qualifier:
according to guideline
Guideline:
other: Japanese Substance Control Law (JSCL) Test Guideline III. 1 Gene Mutation Test With Bacteria
Principles of method if other than guideline:
Salmonella/microsome mutagenicity test (Ames test) (plate incorporation) was performed to assess the mutagenic nature of the test chemical.
GLP compliance:
yes
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
N-[4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]phenyl]acetamide
EC Number:
267-636-0
EC Name:
N-[4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]phenyl]acetamide
Cas Number:
67905-17-3
Molecular formula:
C22H16N2O4
IUPAC Name:
N-[4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]phenyl]acetamide
Test material form:
solid: particulate/powder
Details on test material:
- Name of test material : Polysynthrene Blue R
- Molecular formula): C22H16N2O4
- Molecular weight : 372.37 g/mol
- Smiles notation : O=C(Nc1ccc(Nc2c3c(c(O)cc2)C(=O)c2c(cccc2)C3=O)cc1)C
- InChl: 1S/C22H16N2O4/c1-12(25)23-13-6-8-14(9-7-13)24-17-10-11-18(26)20-19(17)21(27)15-4-2-3-5-16(15)22(20)28/h2-11,24,26H,1H3,(H,23,25)
- Substance type: Organic
- Physical state: Blue Powder
- Content: 83.5% by HPLC
14.3% organic by-productes by HPLC
2.1% Water by Karl-Fischer Titration
0.1% inorganic impurities by sulphated ash

- Name of test material : N-[4-[(9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthryl)amino]phenyl]acetamide- Molecular formula): C22H16N2O4- Molecular weight : 372.378 g/mol- Smiles notation : O=C(Nc1ccc(Nc2c3c(c(O)cc2)C(=O)c2c(cccc2)C3=O)cc1)C- InChl: 1S/C22H16N2O4/c1-12(25)23-13-6-8-14(9-7-13)24-17-10-11-18(26)20-19(17)21(27)15-4-2-3-5-16(15)22(20)28/h2-11,24,26H,1H3,(H,23,25)- Substance type: Organic- Physical state: Powder

Method

Target gene:
Histidine for Salmonella typhimurium strains and tryptophan for E.coli strains
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Details on mammalian cell type (if applicable):
Not applicable
Additional strain / cell type characteristics:
other: Salmonella typhimurium strains TA98: hisD3052 rfa uvr B+R TA100: hisG46 rfa uvr B+R Ta1535: hisG46 rfa uvrB TA1537: hisC3076 rfa uvrB Escherichia coli WP2uvrA: pKM101
Species / strain / cell type:
E. coli WP2 uvr A pKM 101
Details on mammalian cell type (if applicable):
Not applicable
Additional strain / cell type characteristics:
other: pKM101
Metabolic activation:
with and without
Metabolic activation system:
S9 metabolic activation system was prepared from liver of male Sprague Dawley rat homogenate
Test concentrations with justification for top dose:
Plate incorporation assay:
With: 0, 50, 160, 500, 1600 or 5000 µg/plate
Without: 0, 50, 160, 500, 1600 or 5000 µg/plate
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The test chemical was solube in DMSO
Controls
Untreated negative controls:
yes
Remarks:
Untreated control
Negative solvent / vehicle controls:
yes
Remarks:
DMSO
True negative controls:
no
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
9-aminoacridine
sodium azide
other: 2-nitrofluorene (TA98, -S9), 2-aminoanthracene (All strains, +S9)
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation)
- Cell density at seeding (if applicable): No data

DURATION
- Preincubation period: No data
- Exposure duration: 48 hrs
- Expression time (cells in growth medium): 48 hrs
- Selection time (if incubation with a selection agent): No data
- Fixation time (start of exposure up to fixation or harvest of cells): No data

SELECTION AGENT (mutation assays): No data

SPINDLE INHIBITOR (cytogenetic assays): No data

STAIN (for cytogenetic assays): No data

NUMBER OF REPLICATIONS: Triplicate

METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: No data

NUMBER OF CELLS EVALUATED: No data

NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE (if in vitro cytogenicity study in mammalian cells): No data

CRITERIA FOR MICRONUCLEUS IDENTIFICATION: No data

DETERMINATION OF CYTOTOXICITY
- Method: mitotic index; cloning efficiency; relative total growth; other: Yes
- Any supplementary information relevant to cytotoxicity: Toxicity was assessed after microscopic thinning of the bacterial lawn and/or reduction of the number of spontaneously occuring mutants compared to the corresponding solvent control value

OTHER EXAMINATIONS:
- Determination of polyploidy: No data
- Determination of endoreplication: No data
- Methods, such as kinetochore antibody binding, to characterize whether micronuclei contain whole or fragmented chromosomes (if applicable): No data

- OTHER: No data
Rationale for test conditions:
No data
Evaluation criteria:
The test chemical was considered positive if-
- it produces atleast 2-fold increase in the mean number of revertants/plate of atleast one of the tester strains over the mean number of revertants per plate of the appropriate vehicle control at complete bacterial background lawn
- it induces a dose related increase in the mean number of revertants per plate of at least one of the test strains over the mean number of revertants per plate of the appropriate vehicle in atleast two or three concentrations of the test item at complete bacterial background lawn

If the aboce critera is not achieved, it is considered to show no mutagenic activity in the system
Statistics:
No data

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium, other: TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
E. coli WP2 uvr A pKM 101
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: No data
- Effects of osmolality: No data
- Evaporation from medium: No data
- Water solubility: No data
- Precipitation: Visible precipitation was observed on plates at 160 µg/plate and above
- Definition of acceptable cells for analysis: No data
- Other confounding effects: No data

RANGE-FINDING/SCREENING STUDIES: No data

CYTOKINESIS BLOCK (if used)
- Distribution of mono-, bi- and multi-nucleated cells: No data

NUMBER OF CELLS WITH MICRONUCLEI
- Number of cells for each treated and control culture: No data
- Indication whether binucleate or mononucleate where appropriate: No data

HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: No data
- Negative (solvent/vehicle) historical control data: No data

ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Measurement of cytotoxicity used: No data
- Other observations when applicable: No data
Remarks on result:
other: No mutagenic potential

Any other information on results incl. tables

Table: Results of the mutagenicity test for the test chemical

TA100

S9

Dose levelsµg/plate

Number of revertants/plate

Mean

SD

Ratio dose/control

p

Plate 1

Plate 1

Plate 3

+

2-Aminoanthracene

1703

1512

1460

1558.3

128.0

12.7

 

+

Negative control

124

128

119

123.7

4.5

-

 

+

DMSO

111

134

122

122.3

11.5

-

 

+

50

135

116

126

125.7

9.5

1.0

 

+

160

137

130

151

139.3

10.7

1.1

P

+

500

135

125

127

129.0

5.3

1.1

P

+

1600

129

127

139

131.7

6.4

1.1

P

+

5000

122

104

110

112.0

9.2

0.9

p

-

Sodium azide

586

539

620

581.7

40.7

5.4

 

-

Negative control

123

115

119

119.0

4.0

-

 

-

DMSO

109

119

98

108.7

10.5

-

 

-

50

109

109

104

107.3

2.9

1.0

 

-

160

109

103

130

114.0

14.2

1.0

P

-

500

109

98

109

105.3

6.4

1.0

P

-

1600

103

108

115

108.7

6.0

1.0

P

-

5000

109

98

79

95.3

15.2

0.9

P

P: Precipitated

TA1535

S9

Dose levelsµg/plate

Number of revertants/plate

Mean

SD

Ratio dose/control

p

Plate 1

Plate 1

Plate 3

+

2-Aminoanthracene

440

439

456

445.0

9.5

47.7

 

+

Negative control

4

7

10

7.0

3.0

-

 

+

DMSO

10

9

9

9.3

0.6

-

 

+

50

8

8

4

6.7

2.3

0.7

 

+

160

11

7

5

7.7

3.1

0.8

P

+

500

11

5

4

6.7

3.8

0.7

P

+

1600

7

10

8

8.3

1.5

0.9

P

+

5000

12

6

7

8.3

3.2

0.9

p

-

Sodium azide

193

1889

143

175.0

37.8

32.8

 

-

Negative control

13

6

11

10.0

3.6

-

 

-

DMSO

6

4

6

5.3

1.2

-

 

-

50

7

4

5

5.3

1.5

1.0

 

-

160

6

7

5

6.0

1.0

1.1

P

-

500

10

7

3

6.7

3.5

1.3

P

-

1600

6

8

5

6.3

1.5

1.2

P

-

5000

8

5

10

7.7

2.5

1.4

P

P: Precipitated

 

TA1537

S9

Dose levelsµg/plate

Number of revertants/plate

Mean

SD

Ratio dose/control

p

Plate 1

Plate 1

Plate 3

+

2-Aminoanthracene

99

102

93

98.0

4.6

5.9

 

+

Negative control

19

17

12

16.0

3.6

-

 

+

DMSO

18

16

16

16.7

1.2

-

 

+

50

28

22

17

22.3

5.5

1.3

 

+

160

20

23

26

23.0

3.0

1.4

P

+

500

24

24

20

22.7

2.3

1.4

P

+

1600

19

23

24

22.0

2.6

1.3

P

+

5000

14

17

27

19.3

6.8

1.2

p

-

9-aminoacridine

270

222

153

215.0

58.8

23.0

 

-

Negative control

12

15

8

11.7

3.5

-

 

-

DMSO

7

9

12

9.3

2.5

-

 

-

50

13

11

16

13.3

2.5

1.4

 

-

160

9

11

8

9.3

1.5

1.0

P

-

500

8

7

12

9.0

2.6

1.0

P

-

1600

15

13

10

12.7

2.5

1.4

P

-

5000

10

13

11

11.3

1.5

1.2

P

P: Precipitated

 

TA98

S9

Dose levelsµg/plate

Number of revertants/plate

Mean

SD

Ratio dose/control

p

Plate 1

Plate 1

Plate 3

+

2-Aminoanthracene

1054

1120

1076

1083.3

33.6

54.2

 

+

Negative control

18

23

23

21.3

2.9

-

 

+

DMSO

19

21

20

20.0

1.0

-

 

+

50

21

18

14

17.7

3.5

0.9

 

+

160

28

27

21

25.3

3.9

1.3

P

+

500

30

21

28

26.3

4.7

1.3

P

+

1600

32

26

34

30.7

4.2

1.5

P

+

5000

20

34

34

29.3

8.1

1.5

p

-

2-nitrofluorene

301

299

301

300.3

1.2

26.5

 

-

Negative control

12

14

9

11.7

2.5

-

 

-

DMSO

14

13

7

11.3

3.8

-

 

-

50

14

14

8

12.0

3.5

1.1

 

-

160

8

14

13

11.7

3.2

1.0

P

-

500

16

13

12

13.7

2.1

1.2

P

-

1600

13

4

12

9.7

4.9

0.9

P

-

5000

7

11

10

9.3

2.1

0.8

P

P: Precipitated

 

E.coli WP2uvrA

S9

Dose levelsµg/plate

Number of revertants/plate

Mean

SD

Ratio dose/control

p

Plate 1

Plate 1

Plate 3

+

2-Aminoanthracene

125

97

88

103.3

19.3

7.0

 

+

Negative control

15

18

11

14.7

3.5

-

 

+

DMSO

16

11

17

14.7

3.2

-

 

+

50

17

19

17

17.7

1.2

1.2

 

+

160

16

15

15

15.3

0.6

1.0

P

+

500

15

11

18

14.7

3.5

1.0

P

+

1600

14

16

14

14.7

1.2

1.0

P

+

5000

16

13

12

13.7

2.1

0.9

p

-

9-NQO

529

578

572

559.7

26.7

31.7

 

-

Negative control

17

17

23

19.0

3.5

-

 

-

DMSO

26

14

13

17.7

7.2

-

 

-

50

21

15

15

17.0

3.5

1.0

 

-

160

18

14

17

16.3

2.1

0.9

P

-

500

15

20

20

18.3

2.9

1.0

P

-

1600

19

17

15

17.0

2.0

1.0

P

-

5000

12

19

18

16.3

3.8

0.9

P

P: Precipitated

 

Applicant's summary and conclusion

Conclusions:
The registered substance was tested non-mutagenic (negative) both in the presence and absence of S9 metabolic activation in Salmonella typhimurium TA1535, TA1537, TA98 and TA100 and Escherichia coli WP2uvrA tester strains. The test was performed according to OECD TG 471 and in compliance with OECD Principles of Good Laboratory Practice.
Executive summary:

Salmonella/microsome mutagenicity test (Ames test) was performed to assess the mutagenic nature of theregistered substance. The study was conducted according to the plate incorporation method and in the presence and absence of S9 metabolic activation system using Salmonella typhimurium TA1535, TA1537, TA98 and TA100 and Escherichia coli WP2uvrA tester strains. The test chemical was dissolved in DMSO and used at concentrationsof 0, 50, 160, 500, 1600 or 5000 µg/plate. The plates were incubated for 48 hrs and observed for revertant colonies. Concurrent solvent(Dimethyl sulfoxide),negative controland positive control substances were also included in the study. The test chemical did not induce a relevant or dose-dependent increase in the number of revertants colonies at any concentrations tested either in the presence or absence of S9 metabolic activation system using Salmonella typhimurium TA1535, TA1537, TA98 and TA100 and Escherichia coli WP2uvrA tester strains.